Alpha-9 Oncology
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that develops targeted radiotherapeutics for cancer treatment.
$175M Series B+ ·
Led by Lightspeed · Source: fundraisingfox.com
Funding history ↓Signals
About Alpha-9 Oncology
The company creates bespoke molecules to treat cancer cells. Alpha-9 Oncology focuses on solid and hematologic malignancies.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $175M | fundraisingfox.com |
Timeline
- Website created
Founders and team
DP
David Perrin founderLinkedIn · source: a9oncology.com- FBFrançois Bénard foundersource: a9oncology.com
- KLKuo-Shyan Lin foundersource: a9oncology.com
IM
Ian McBeath CEOPB
Paul Blanchfield Chief Executive OfficerRM
Robert Meehan Chief Medical Officer
Investors
AAberdeen
AAndreessen Horowitz
BBiotechnology Value Fund
DDelos Capital
DDigitalis Ventures
FFrazier Life Sciences
GGeneral Catalyst
JJanus Henderson Investors
LLightspeedlead investor
LLongitude Capital
LLumira Ventures
NNextech Invest
RRA Capital Management
SSamsara Biocapital
Companies like Alpha-9 Oncology
AAdvanCell$315M Series B+ · Jul 2026
CCellCentric$220M Series B+ · May 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
AAkamis Bio$60M Series A · Dec 2024
MMariana Oncology$175M Series B+ · Sep 2023
SSkopos Bio$12M Seed · Sep 2026
Other companies backed by Lightspeed
IIndex Industries$50M Seed · Nov 2026NNominal$240M Series B+ · Nov 2026
HHypersonica$112.16M · Nov 2026
DDren Bio$350M Series B+ · Oct 2026WWarp Sciences$215M Series A · Oct 2026
RReliable Robotics$115M Series B+ · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/alpha-9-oncology (get a free API key).